Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryDental CBCT AI and viewer platform for radiological reports, 3D visualization, and FDA-cleared second-read support for periapical radiolucency detection.
Dental and oral-radiology teams that need CBCT-focused second-reader support and structured reports while keeping licensed clinicians accountable.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Diagnocat as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Use the FDA-cleared CBCT indication narrowly: second-read support for periapical radiolucency in permanent teeth for trained dental professionals, not a replacement for complete clinical judgment. |
|---|---|
| Privacy | Review DICOM routing, cloud storage, desktop or web viewer access, report sharing, support access, HIPAA materials, SOC 2 evidence, retention, and business-associate terms. |
| Evidence | Validate against local CBCT cases, scanner protocols, oral-radiologist review, periapical-radiolucency prevalence, segmentation accuracy, and how often clinicians dismiss AI findings. |
| Workflow | Best deployed after CBCT necessity is independently determined, with clinician review of heat maps, report edits, patient-communication boundaries, and documented final interpretation. |
Diagnocat describes FDA-cleared dental image-processing, 3D visualization, radiological reports, and HIPAA/SOC 2-aligned product claims; FDA K252934 lists Diagnocat as a CADe second-read tool for periapical radiolucency on previously acquired maxillofacial CBCT scans of permanent teeth in adults.
Not for: Replacing a complete CBCT review, use before a clinician independently determines CBCT is clinically justified, unsupported patient ages, or broad claims beyond the cleared indication.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.